Alimentiv

Poor trial design is a leading cause of issues in clinical trials. We’ve created a comprehensive guide and checklist to help you optimize trial design, avoid pitfalls, enhance precision, minimize risks to patients, and maximize ROI. Download our guide now! 👉 https://lnkd.in/gptPg54t #Alimentiv #ClinicalTrialDesign #ClinicalResearch #MedicalResearch #Biostatistics

In the complex field of clinical research, partnering with a specialized CRO is key. Alimentiv has over 30 years of GI-related experience and offers end-to-end clinical trial services. Alimentiv’s unmatched expertise spans all trial phases, starting from clinical trial management to imaging and precision medicine. Our team partners with you to bring you innovative solutions for your studies. Download our brochure to learn why we are the trusted partner for leading pharmaceutical & biotech companies! https://bit.ly/3AxnR5d #Alimentiv #GI #ImagingSolutions #PrecisionMedicine #MedicalResearch

It is exciting to see that Nature has selected spatial proteomics as its 2024 Method of the Year! The latest Nature publication shines a spotlight on spatial proteomics techniques, offering insightful commentaries on the field, computational tools, current research applications, and the integration of spatial proteomics with other datasets. At Alimentiv, we are thrilled about the potential applications of spatial proteomics and spatial transcriptomics (Nature’s 2020 Method of the Year), especially in the context of #GI diseases. At #DDW 2024, we presented a poster demonstrating how histology enhances spatial transcriptomics datasets, uncovering cellular niches linked to histological inflammation (links in comments 🔗). Learn more at https://acelabio.com ♻️ Share this if you find it interesting 🔔 Follow Alimentiv for insights you won't want to miss 📩 DM me to discuss your spatial bio projects

🔎 Unlock deeper insights from your tissue samples with AcelaBio spatial transcriptomics services. Find out how Alimentiv’s specialty #histopathology lab leverages the 10x Visium platform to uncover novel biomarkers and accelerate drug development for GI and liver diseases. Read the interview with Dr. Wendy Teft for the full story! 🔗 https://loom.ly/aMamMiU #Alimentiv #ClinicalTrials #SpatialBiology #spatialtranscriptomics #10Xgenomics #GI #Gastroenterology

Timely and accurate diagnosis and prognosis, frequent monitoring, and the prediction of the response to therapy are critical for effective Crohn’s disease management, but better diagnostic tools are needed. Delays in diagnosis, infrequent monitoring, and the lack of effective treatments often lead to severe complications as the disease progresses. Our Diagnostics focus area is dedicated to advancing the identification, development, and validation of better diagnostic tools to improve the lives of people living with Crohn’s disease. One common yet devastating complication of Crohn’s disease is a narrowing of the intestines, known as stricturing Crohn’s disease, that leads to bowel obstruction and the need for surgery. Currently, there is a lack of tools that are required to monitor strictures and for the clinical development of effective therapies for these patients. The Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium is a group of clinician researchers led by Drs. Florian Rieder, Brian Feagan, and JG Fletcher from Cleveland Clinic, Alimentiv, and Mayo Clinic, respectively. The consortium is focused on the development of diagnostic tools, including a patient-reported outcome measure and standard indices for non-invasive monitoring of strictures using MRI, CT imaging, and intestinal ultrasound to support the development of anti-fibrotic therapeutics in clinical trials to improve the care and treatment of people living with stricturing Crohn’s disease. Learn more about our Diagnostic strategy at the link in our bio. #CrohnsDisease #CCAwarenessWeek #IBD #STARConsortium

🌎 Why join Alimentiv’s site network? With over 30 years of global expertise in GI clinical trials, Alimentiv brings unmatched insights into the GI therapeutic landscape and current practices. Key Benefits: · Access to GI clinical trial opportunities · Improved feasibility: We connect studies with site and investigator interest, experience and capacity · Start-up efficiencies · Site support · GI trained CRA and trial management team with low turn-over · ASN team oversight to manage Alimentiv-site relationships Join our site network today 👉 https://lnkd.in/gVu85wym #Alimentiv #ClinicalTrials #Gastroenterology

This week (December 1-7) is Crohn's & Colitis Awareness Week! 💜 Crohn’s disease and ulcerative colitis, part of the inflammatory bowel disease (IBD) family, impact millions worldwide. 🌎 At Alimentiv, we are dedicated to raising awareness and continuing to advocate for research that supports those affected by these chronic conditions. We are proud to play a pivotal role in advancing therapies that improve the lives of patients and their families. Together, we can make a difference. 👉 https://lnkd.in/gsmFidVv #Alimentiv #CrohnsAndColitisAwarenessWeek #GI #Gastroenterology #CrohnsDisease #UlcerativeColitis

Happy Thanksgiving to all our American colleagues, clients, and partners! 🦃 This year, we’re especially thankful for the opportunity to contribute to advancing medical research and improving patient outcomes. Your collaboration, innovation, and trust inspire us every day to push boundaries in clinical trials and healthcare. Wishing you and your loved ones a joyous and restful Thanksgiving celebration! #Thanksgiving #Gratitude #Alimentiv #ClinicalResearch

Connect with Alimentiv at the 2024 #NZSG Conference, November 27-29! 🇳🇿 Sharon Ewen, Alimentiv’s Site Network representative, will be attending the New Zealand Society of Gastroenterology’s Annual Scientific Meeting. Stop by and chat with Sharon about opportunities to collaborate with our extensive site network. 📅 November 27-29, 2024 📍Hamilton, New Zealand We look forward to connecting with you! Schedule a meeting: https://lnkd.in/gBixsMt6 #Alimentiv #ClinicalTrials #GI

⭐️ That’s a wrap on this year’s #AASLD conference! We’re thrilled to have attended the 75th Liver Meeting. Thank you to everyone who stopped by our booth and shared their insights with our team. Missed us at the conference? You can get in touch with our experts here 👉 https://bit.ly/3TZHzhH #Alimentiv #AASLD #TLM2024 #ClinicalTrials #LiverDiseases #GI #LiverMeeting2024 #LiverResearch #Hepatology #ClinicalResearch ___________ Music: Vacation Beat by Soundroll